Stock listing

Hangzhou Tigermed Consulting Co., Ltd. Class A

Selected listing: A2QALD · LSX · EUR · DE

Hangzhou Tigermed Consulting Co., Ltd. Class A (LS Exchange: A2QALD), Health Technology. Latest release Sep 4, 2026: Hangzhou Tigermed Consulting : Tigermed…

A2QALD:LSXEURDEUpdated September 25, 2026

Ticker: LS Exchange: A2QALD
Asset type: Stock
Sector: Health Technology
Industry: Biotechnology
Exchange: LS Exchange
Currency: EUR

Latest news from Hangzhou Tigermed Consulting Co., Ltd. Class A

Hangzhou Tigermed Consulting : Tigermed and Veeda Lifesciences Forge Strategic Clinical Research for Global Drug Development

September 3, 2026

Tigermed Announces 2026 Interim Results

August 28, 2026

Tigermed Announces 2025 Annual Results

March 30, 2026

Tigermed Selected as "2025 Forbes China Go-International Flagship Brands" Top 30

November 6, 2025

Tigermed Receives MSCI ESG AAA Rating

August 17, 2025

All Hangzhou Tigermed Consulting Co., Ltd. Class A news →

Research Hangzhou Tigermed Consulting Co., Ltd. Class A

Hangzhou Tigermed Consulting Co., Ltd. Class A company profile

View the public company page for Hangzhou Tigermed Consulting Co., Ltd. Class A on 6ix.

Hangzhou Tigermed Consulting Co., Ltd. Class A news

Read company news and market updates connected to Hangzhou Tigermed Consulting Co., Ltd. Class A.

Hangzhou Tigermed Consulting Co., Ltd. Class A investor events

Find investor webinars, events, and replay context for Hangzhou Tigermed Consulting Co., Ltd. Class A.